17 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table Insulin ... SGLT2 inhibitors ... comparison #management #endocrinology ... #dm2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
receptor agonist, SGLT2i ... mealtime • If NPO ... #Mellitus #DM2 ... #pharmacology # ... comparison #table #endocrinology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... - Pharmacology ... #Inhibitors #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
Effects on body weight of various classes of type-2 diabetes medications.
 - Metformin - Weight Loss
medications ... Weight Loss + - SGLT ... -2 inhibitors - ... Weight Gain ++ - Insulin ... weightgain #comparison #pharmacology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... SGLT2 inhibitors ... #Inhibitors #Pharmacology ... #Medications #DM2 ... #Diabetes #Endocrinology
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Hypoglycemics in Diabetes ... Management 1 INSULIN ... Prandase) • SGLT ... #Management #pharmacology ... #DM2 #DMII #Classification
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... -> Stimulates Insulin ... #Pharmacology #Management ... #Diabetes #DM2 ... #Endocrinology
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
: Weight-Based Dosing ... #dosing #estimation ... Weight #Based #pharmacology ... #endocrinology ... #diabetes #DM2
Metformin - First Line Treatment for Diabetes Type 2
• Start with initial dose of 500 mg
Metformin - First Line Treatment ... for Diabetes Type ... form and consider using ... #Titration #Pharmacology ... #Diabetes #DM2
Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing Indications
Significant Adverse Drug Effects
Definition of EuDKA
 • Metabolic acidosis with pH
Ketoacidosis (EuDKA) SGLT2 ... Inhibitors Increasing ... Indications Significant ... acidosis with pH ... diagnosis #management #endocrinology